PeptiDream Past Earnings Performance
Past criteria checks 2/6
PeptiDream has been growing earnings at an average annual rate of 26.4%, while the Biotechs industry saw earnings growing at 24.8% annually. Revenues have been growing at an average rate of 45.2% per year. PeptiDream's return on equity is 7.5%, and it has net margins of 10.6%.
Key information
26.4%
Earnings growth rate
25.5%
EPS growth rate
| Biotechs Industry Growth | 31.9% |
| Revenue growth rate | 45.2% |
| Return on equity | 7.5% |
| Net Margin | 10.6% |
| Next Earnings Update | 14 May 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How PeptiDream makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 28,712 | 3,035 | 6,673 | 3,155 |
| 30 Sep 23 | 38,187 | 11,281 | 6,970 | 3,286 |
| 30 Jun 23 | 31,254 | 7,956 | 6,845 | 3,257 |
| 31 Mar 23 | 31,396 | 8,135 | 6,833 | 3,229 |
| 31 Dec 22 | 26,852 | 7,554 | 5,830 | 2,915 |
| 30 Sep 22 | 12,811 | 57 | 4,944 | 1,888 |
| 30 Jun 22 | 11,511 | 1,705 | 3,862 | 1,164 |
| 31 Mar 22 | 8,326 | 2,341 | 2,759 | 394 |
| 31 Dec 21 | 9,366 | 3,606 | 2,590 | 0 |
| 30 Sep 21 | 15,607 | 7,110 | 2,693 | 0 |
| 30 Jun 21 | 11,449 | 4,329 | 2,623 | 0 |
| 31 Mar 21 | 12,743 | 5,226 | 2,527 | 0 |
| 31 Dec 20 | 11,677 | 4,448 | 2,538 | 0 |
| 31 Dec 19 | 2,075 | -977 | 2,506 | 0 |
| 30 Jun 19 | 7,217 | 2,770 | 1,986 | 0 |
| 30 Jun 18 | 6,427 | 2,335 | 1,737 | 0 |
| 31 Mar 18 | 4,616 | 895 | 1,797 | 0 |
| 30 Sep 17 | 4,271 | 962 | 1,647 | 0 |
| 30 Jun 17 | 4,896 | 1,891 | 1,046 | 0 |
| 31 Mar 17 | 3,064 | 769 | 826 | 0 |
| 31 Dec 16 | 4,457 | 1,685 | 764 | 0 |
| 30 Sep 16 | 4,735 | 1,823 | 739 | 0 |
| 30 Jun 16 | 4,328 | 1,581 | 694 | 0 |
| 31 Mar 16 | 4,620 | 1,976 | 603 | 0 |
| 31 Dec 15 | 3,121 | 1,203 | 481 | 0 |
| 30 Sep 15 | 2,722 | 1,063 | 409 | 0 |
| 30 Jun 15 | 2,474 | 1,004 | 362 | 0 |
| 31 Mar 15 | 757 | 46 | 310 | 0 |
| 31 Dec 14 | 739 | 67 | 307 | 0 |
| 30 Sep 14 | 786 | 118 | 301 | 0 |
| 30 Jun 14 | 819 | 149 | 303 | 0 |
| 30 Jun 13 | 678 | 137 | 250 | 0 |
Quality Earnings: 4587 has high quality earnings.
Growing Profit Margin: 4587's current net profit margins (10.6%) are lower than last year (28.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4587's earnings have grown significantly by 26.4% per year over the past 5 years.
Accelerating Growth: 4587's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 4587 had negative earnings growth (-59.8%) over the past year, making it difficult to compare to the Biotechs industry average (-2%).
Return on Equity
High ROE: 4587's Return on Equity (7.5%) is considered low.